HTSUY (Hisamitsu Pharmaceutical Co) Construction In Progress: $0 Mil (As of Nov. 2025)


HTSUY Hisamitsu Pharmaceutical Co Inc HTSUY
87 GF Score
Price $2.94
GF Value $2.39
Valuation Modestly Overvalued
View Full Analysis

What is Hisamitsu Pharmaceutical Co Construction In Progress?

Hisamitsu Pharmaceutical Co HTSUY 87 Construction In Progress is $0 Mil as of Nov. 2025. GuruFocus rates HTSUY with a GF Score™ of 87/100 and a GF Value™ of $2.39 (Modestly Overvalued).

Hisamitsu Pharmaceutical Co's annual construction in progress declined from Feb. 2024 ($76 Mil) to Feb. 2025 ($38 Mil) and declined from Feb. 2025 ($38 Mil) to Feb. 2026 ($23 Mil).

Hisamitsu Pharmaceutical Co Construction In Progress Historical Data

* Premium members only.

The historical data trend for Hisamitsu Pharmaceutical Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hisamitsu Pharmaceutical Co Construction In Progress Chart

Hisamitsu Pharmaceutical Co Annual Data
Trend Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25 Feb26
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.63 46.73 75.93 38.17 23.17

Hisamitsu Pharmaceutical Co Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.17 0.00 0.00 0.00 23.17
HTSUY
87GF Score
Hisamitsu Pharmaceutical Co Inc HTSUY
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hisamitsu Pharmaceutical Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of $0 Mil mean?
Hisamitsu Pharmaceutical Co (HTSUY) has a Construction In Progress of $0 Mil as of Nov. 2025. Construction in Progress records the amount of construction work that is not complete. View historical data on Hisamitsu Pharmaceutical Co and its competitors.
Is Hisamitsu Pharmaceutical Co's Construction In Progress too high?
Hisamitsu Pharmaceutical Co's current Construction In Progress is $0 Mil. Overall, Hisamitsu Pharmaceutical Co has a GF Score™ of 87/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hisamitsu Pharmaceutical Co's Construction In Progress compare to ESPR and AMPH?
Hisamitsu Pharmaceutical Co's Construction In Progress of $0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Hisamitsu Pharmaceutical Co and its competitors. Hisamitsu Pharmaceutical Co's current Construction In Progress is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hisamitsu Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Hisamitsu Pharmaceutical Co (HTSUY) is currently considered Modestly Overvalued. The stock's GF Value™ is $2.39, compared to a current price of $2.94 — trading 23% above its estimated fair value. The current Construction In Progress is $0 Mil. Hisamitsu Pharmaceutical Co's overall GF Score™ is 87/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Hisamitsu Pharmaceutical Co (HTSUY), the current Construction In Progress is $0 Mil as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hisamitsu Pharmaceutical Co (HTSUY) Overvalued in 2026?

Based on GuruFocus' analysis, Hisamitsu Pharmaceutical Co stock appears to be overvalued. The current stock price of $2.94 is trading 23% above its estimated GF Value™ of $2.39. GuruFocus considers Hisamitsu Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for HTSUY:

  • Construction In Progress: $0 Mil
  • GF Value™: $2.39 vs. price of $2.94 (23% above fair value)
  • GF Score™: 87/100

No single metric tells the full story. See the HTSUY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hisamitsu Pharmaceutical Co Business Description

Address 408 Tashiro Daikancho, Saga Prefecture, Tosu, JPN, 841-0017
Hisamitsu Pharmaceutical Co Inc is engaged in the research, development, manufacturing, procurement, and sale of pharmaceutical products. The company operates a single business segment, focusing on medical and general pharmaceuticals both in Japan and overseas. It markets drugs under the Salonpas, Nobinobi / Salonsip, Butenalock, and Mohrus brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions, and ointments.
87GF Score

Get the complete analysis for HTSUY

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.94
Price
$2.39
GF Value